close 73% inwestorów detalicznych traci pieniądze podczas handlu CFD z tym dostawcą. Inwestowanie wiąże się z ryzykiem i nie jest odpowiednie dla wszystkich inwestorów. Kontrakty CFD są złożonymi instrumentami i wiążą się z dużym ryzykiem szybkiej utraty środków pieniężnych z powodu dźwigni finansowej. 73% rachunków inwestorów detalicznych notuje stratę pieniędzy podczas handlu kontraktami CFD z tym dostawcą. Upewnij się, czy rozumiesz, jak działają kontrakty CFD, i czy możesz pozwolić sobie na wysokie ryzyko utraty pieniędzy.
Change languagePolski
Pulpit

LLY

1,068.91

-0.6%↓

JNJ

206.38

-0.11%↓

ABBV

225.01

-1.21%↓

UNH

325.65

-1.33%↓

AZN

91.26

-1.59%↓

LLY

1,068.91

-0.6%↓

JNJ

206.38

-0.11%↓

ABBV

225.01

-1.21%↓

UNH

325.65

-1.33%↓

AZN

91.26

-1.59%↓

LLY

1,068.91

-0.6%↓

JNJ

206.38

-0.11%↓

ABBV

225.01

-1.21%↓

UNH

325.65

-1.33%↓

AZN

91.26

-1.59%↓

LLY

1,068.91

-0.6%↓

JNJ

206.38

-0.11%↓

ABBV

225.01

-1.21%↓

UNH

325.65

-1.33%↓

AZN

91.26

-1.59%↓

LLY

1,068.91

-0.6%↓

JNJ

206.38

-0.11%↓

ABBV

225.01

-1.21%↓

UNH

325.65

-1.33%↓

AZN

91.26

-1.59%↓

Strona główna・Stock List・Karyopharm Therapeutics Inc
Search

Karyopharm Therapeutics Inc

Open

SectorHealthcare

5.59

Strong Buy

Price update 1 gru 2025, 17:34 UTC

BuySell

Overview

Share price change

24h

Current

Min

5.29

Max

6.08

Key metrics

By Trading Economics

Income

4.1M

-33M

Sales

6.1M

44M

EPS

-3.82

Profit margin

-75.213

Employees

279

EBITDA

1.8M

-23M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+146.09% upside

Market Stats

By TradingEconomics

Market Cap

-7.4M

95M

Previous open

5.59

Previous close

5.59

News Sentiment

By Acuity

44%

56%

154 / 374 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Bullish Evidence

5.9501 / 7.66 Support & Resistance

Karyopharm Therapeutics Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

28 lis 2025, 15:29 UTC

Major Market Movers
Acquisitions, Mergers, Takeovers

China's Jiangxi Copper Rejected by SolGold in $1 Billion Takeover Approach

DJ

Read

30 lis 2025, 23:50 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

DJ

Read

30 lis 2025, 23:50 UTC

Market Talk

Nikkei May Decline Amid Uncertainty Over U.S. Economy, Japan Earnings -- Market Talk

DJ

Read

30 lis 2025, 22:24 UTC

Market Talk

Global Equities Roundup: Market Talk

DJ

Read

30 lis 2025, 22:24 UTC

Market Talk

Australian Equities Typically Rise in Year Before Rate Hikes Start -- Market Talk

DJ

Read

30 lis 2025, 07:30 UTC

Acquisitions, Mergers, Takeovers

Strategy Insiders Kept Buying Preferred Stock as Bitcoin Price Slid -- Barrons.com

DJ

Read

28 lis 2025, 21:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

DJ

Read

28 lis 2025, 19:59 UTC

Market Talk

Oil Futures Settle Lower in Slow Black Friday Trade -- Market Talk

DJ

Read

28 lis 2025, 19:47 UTC

Market Talk

U.S. Natural Gas Lifted By Cold Weather Outlook -- Market Talk

DJ

Read

28 lis 2025, 18:16 UTC

Market Talk

Global Equities Roundup: Market Talk

DJ

Read

28 lis 2025, 18:16 UTC

Market Talk

Messy Canada GDP Data Still Seen as Cause for Optimism in 2026 -- Market Talk

DJ

Read

28 lis 2025, 18:08 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

DJ

Read

28 lis 2025, 18:08 UTC

Market Talk

Messy Canada GDP Data Still Seen as Cause for Optimism in 2026 -- Market Talk

DJ

Read

28 lis 2025, 17:48 UTC

Market Talk

Bank of Canada May Revise Up Inflation Projections After GDP Data -- Market Talk

DJ

Read

28 lis 2025, 17:20 UTC

Market Talk

Auto & Transport Roundup: Market Talk

DJ

Read

28 lis 2025, 16:50 UTC

Acquisitions, Mergers, Takeovers

Week's Best: Sieg's Stature at Citi Grows -- Barrons.com

DJ

Read

28 lis 2025, 15:51 UTC

Market Talk

Canada Household Spending Edges Lower -- Market Talk

DJ

Read

28 lis 2025, 15:33 UTC

Market Talk

Crude Futures Gain as U.S. Market Reopens -- Market Talk

DJ

Read

28 lis 2025, 15:21 UTC

Market Talk

Gold Rises on U.S. Rate-Cut Bets After CME Outage -- Market Talk

DJ

Read

28 lis 2025, 15:13 UTC

Market Talk

Dollar Recovers Slightly as Investors Already Price in Fed Rate Cut -- Market Talk

DJ

Read

28 lis 2025, 15:11 UTC

Market Talk

Global Equities Roundup: Market Talk

DJ

Read

28 lis 2025, 15:11 UTC

Market Talk

Canadian National Railway Showing Positive Trend Going Into 2026 -- Market Talk

DJ

Read

28 lis 2025, 14:51 UTC

Market Talk

Canada GDP Report Masks Fragile State of Economy -- Market Talk

DJ

Read

28 lis 2025, 14:41 UTC

Market Talk

Canada's GDP Level Pulled Higher by 'Eye-Opening' Revisions -- Market Talk

DJ

Read

28 lis 2025, 14:37 UTC

Market Talk

U.S. Natural Gas Futures Rise As Temperatures Drop -- Market Talk

DJ

Read

28 lis 2025, 14:33 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

DJ

Read

28 lis 2025, 14:33 UTC

Market Talk

Steep Import Drop Fuels Surprise Lift in Canada GDP -- Market Talk

DJ

Read

28 lis 2025, 14:20 UTC

Market Talk

Too Much Noise in Canada's Surprise 3Q GDP Gain -- Market Talk

DJ

Read

28 lis 2025, 14:10 UTC

Market Talk

Canadian Nowcast Came Closest to Predicting Surprise 3Q Strength -- Market Talk

DJ

Read

28 lis 2025, 13:39 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

DJ

Read

Peer Comparison

Price change

Karyopharm Therapeutics Inc Forecast

Price Target

By TipRanks

146.09% upside

12 Months Forecast

Average 13.83 USD  146.09%

High 21 USD

Low 6 USD

Based on 6 Wall Street analysts offering 12 month price targets forKaryopharm Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

6 ratings

5

Buy

1

Hold

0

Sell

Based on 6 analysts giving stock ratings to Karyopharm Therapeutics Inc - Dist in the past 3 months.

Technical Score

By Trading Central

5.9501 / 7.66Support & Resistance

Short Term

Bullish Evidence

Recent bullish events outweigh bearish events.

Intermediate Term

Strong Bearish Evidence

All events are bearish.

Long Term

No Evidence

There are no events.

Sentiment

By Acuity

154 / 374 Ranking in Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

Other stocks from the sector

LLY

Eli Lilly and Co.

1,068.91

↓-0.6%

JNJ

Johnson and Johnson

206.38

↓-0.11%

ABBV

AbbVie Inc

225.01

↓-1.21%

UNH

UnitedHealth Group Inc

325.65

↓-1.33%

AZN

AstraZeneca PLC ADR

91.26

↓-1.59%
help-icon Live chat